Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

GRACE and Clinical Care Options Online Patient Tool for Ovarian Cancer
Treatment Options From 5 Experts for Advanced Ovarian Cancer: An Online Tool for Patients
Author
Denise Brock
Image
Have you received a diagnosis of ovarian cancer?

GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive Decision Support Tool and downloadable resource to help you understand more about your disease and treatment options, so you can become partners with your oncology team in your cancer care. 

By answering multiple choice questions about your diagnosis, you will be able to review treatment options from five ovarian cancer experts listed below.  

 

 

Clinical Care Options LLC, is a global leader in the development of innovative educational programs and technology platforms. GRACE is pleased to work with CCO on a number of patient materials and tools to help our community in their cancer journey.  

The following list of decision support tools are available on our GRACE and Clinical Care Options Patient Tools partner page:

  • Treatment Options From 5 Experts for Patients With Ovarian Cancer
  • Expert Insights Interactive Decision Support Tool for Advanced NSCLC 
  • Information Regarding Immune Checkpoint Inhibitor Therapy
  • Educational Video - Immunotherapy for Advanced NSCLC: Discussing Goals and Treatments With Your Health Care Provider
  • Expert Insights Interactive Decision Support Tool on HER2+ Early Stage Breast Cancer
  • Expert Insights Interactive Decision Support Tool on Melanoma
  • Expert Insights Interactive Decision Support Tool for Frontline Follicular Lymphoma
  • Educational Videos -Measurable Residual Disease (MRD) in Acute Lymphocytic Leukemia (ALL)
Video Language

Next Previous link

Previous PostNext Post

Related Content

Recent Comments

JOIN THE CONVERSATION
Hello Natalieaster, Welcome…
By JanineT GRACE … on
The information you share is…
By LibbieRohan on
Hi Mel, I'm sorry for the…
By JanineT GRACE … on
Hello.
I know this post is…
By mel on